Novel Monoclonal Antibody Inhibits Tumor Growth in Breast Cancer and Angiosarcoma (IMAGE)

University of North Carolina Health Care

Novel Monoclonal Antibody Inhibits Tumor Growth in Breast Cancer and Angiosarcoma

Caption

Angiosarcoma cells treated with a monoclonal antibody targeting SFRP2 (right) show a significant reduction compared to an untreated control (left).

Credit

DeMore Lab, UNC School of Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.